RNA sequencing uses high-throughput sequencing to measure RNA molecules across the transcriptome, revealing gene expression, transcript structure, splice variation, fusion transcripts, and dynamic molecular activity across biological systems.
RNA-seq transformed transcriptomics by replacing many array-based methods with sequencing-based measurement of RNA abundance and transcript structure. It allows researchers to quantify gene expression, discover novel transcripts, identify fusion events, study alternative splicing, and compare molecular programs across tissues, diseases, treatments, and cell states.
At PanorOmics, RNA-seq is presented as a core transcriptomic technology: a bridge between gene activity, cellular function, disease mechanisms, biomarker discovery, and integrated multi-omics analysis.
Measuring RNA molecules across the transcriptome to understand gene activity, biological states, disease mechanisms, and cellular responses.
Identifying genes whose expression changes across tissues, treatments, disease states, or experimental conditions.
Characterizing alternative transcripts, splice isoforms, and RNA processing events that shape biological function.
Using RNA-seq to support biomarker discovery, disease classification, fusion detection, and precision medicine research.
Transcriptome-wide sequencing of RNA from tissues or cell populations to quantify average gene expression and pathway activity.
RNA sequencing at individual-cell resolution to reveal cell types, cellular heterogeneity, and dynamic transcriptional states.
Sequencing full-length transcripts to improve isoform detection, alternative splicing analysis, and transcript annotation.
Sequencing-based spatial transcriptomics that maps RNA expression within tissue architecture.
Captures coding and non-coding RNA species by depleting ribosomal RNA rather than selecting only polyadenylated transcripts.
Profiles protein-coding messenger RNA expression across samples or biological states.
Measures a broader range of RNA species, including coding and non-coding transcripts.
Profiles gene expression in individual cells to identify cell populations and cell-state transitions.
Captures full-length RNA transcripts to resolve isoforms and complex splicing patterns.
Identifies gene fusions and chimeric transcripts, especially in cancer transcriptomics.
Detects changes in transcript isoform usage across biological or disease conditions.
Related transcriptomic approaches such as RNA expression, alternative splicing, and non-coding RNA analysis are explored across the Transcriptomics Research Center.
Gene expression microarrays and early transcript profiling established the foundation for transcriptome-scale analysis.
High-throughput sequencing technologies made it possible to measure RNA expression through sequencing rather than hybridization.
RNA-seq transformed transcriptomics by enabling high-resolution, transcriptome-wide quantification of gene expression and transcript structure.
Single-cell RNA-seq expanded RNA-seq from bulk samples to individual cells, revealing cellular heterogeneity and rare cell states.
RNA-seq became increasingly important for tumor profiling, fusion detection, biomarker discovery, and disease classification.
Spatial sequencing approaches connected RNA expression with tissue structure, cell neighborhoods, and disease microenvironments.
AI and computational biology increasingly support expression analysis, transcript annotation, cell-state discovery, and clinical RNA-seq interpretation.
Continue exploring the Transcriptomics Research Center.
Continue exploring the Transcriptomics Research Center.
Continue exploring the Transcriptomics Research Center.